A 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((2-phenoxyacetyl)amino)-, potassium salt (1:1), (2S,5R,6R)- DMF (Drug Master File) is a document detailing the whole manufacturing process of 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((2-phenoxyacetyl)amino)-, potassium salt (1:1), (2S,5R,6R)- active pharmaceutical ingredient (API) in detail. Different forms of 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((2-phenoxyacetyl)amino)-, potassium salt (1:1), (2S,5R,6R)- DMFs exist exist since differing nations have different regulations, such as 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((2-phenoxyacetyl)amino)-, potassium salt (1:1), (2S,5R,6R)- USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((2-phenoxyacetyl)amino)-, potassium salt (1:1), (2S,5R,6R)- DMF submitted to regulatory agencies in the US is known as a USDMF. 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((2-phenoxyacetyl)amino)-, potassium salt (1:1), (2S,5R,6R)- USDMF includes data on 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((2-phenoxyacetyl)amino)-, potassium salt (1:1), (2S,5R,6R)-'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((2-phenoxyacetyl)amino)-, potassium salt (1:1), (2S,5R,6R)- USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((2-phenoxyacetyl)amino)-, potassium salt (1:1), (2S,5R,6R)- suppliers with USDMF on PharmaCompass.